Gender disparities in coronavirus disease 2019 clinical trial leadership.

ABSTRACT:

Objectives

To compare the gender distribution of clinical trial leadership in coronavirus disease 2019 (COVID-19) clinical trials.

Methods

We searched https://clinicaltrials.gov/ and retrieved all clinical trials on COVID-19 from 1 January 2020 to 26 June 2020. As a comparator group, we have chosen two fields that are not related to emerging infections and infectious diseases: and considered not directly affected by the pandemic: breast cancer and type 2 diabetes mellitus (T2DM) and included studies within the aforementioned study period as well as those registered in the preceding year (pre-study period: 1 January 2019 to 31 December 2019). Gender of the investigator was predicted using the genderize.io application programming interface. The repository of the data sets used

SUBMITTER: Cevik M 

PROVIDER: S-EPMC7785275 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature